| Code | 88709 | ||||||||||
| MA number | 73/0760/92-S | ||||||||||
| Product Form: | sol inj 5x5 ml (amp.skl.hnedá) | ||||||||||
| MA Status: | D - Marketing Authorisation valid for an unlimited period | ||||||||||
| Type of procedure: | National | ||||||||||
| MAH, country: | BB Pharma a.s., Czechia | ||||||||||
| Therapeutic Class: | 73 - SPASMOLYTICA | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 36 | ||||||||||
| Container: | brown glass ampoule | ||||||||||
| Route of admin.: | Intramuscular or intravenous use |
| Prescription Status: | Medicinal product subject to medical prescription. |
| Legal basis: | Article 10a well-established use application |
| MA issued: | 14.12.1992 |
| Pediatric indication: | Yes |
| Pediatric posology: | Yes |
| Pediatric contraindication: | Yes |
| Pediatric warnings: | Yes |
| PIL: |
PIL_ANALGIN inj_04_2022.pdf
|
| SPC: |
SPC_ANALGIN inj_04_2022.pdf
|
| Dokument: |
DHPC_metamizol_06.12.2024.pdf
|
| Safety feature | Yes |
| Data update: | 12.04.2018 |
